Skip to search formSkip to main contentSkip to account menu

Fendiline

Known as: Benzenepropanamine, gamma-phenyl-N-(1-phenylethyl)-, Fendilin, Fendiline [Chemical/Ingredient] 
Coronary vasodilator; inhibits calcium function in muscle cells in excitation-contraction coupling; proposed as antiarrhythmic and antianginal agents… 
National Institutes of Health

Related topics

Related topics

11 relations

Broader (1)

Calcium Channel Blockers
In Bloodagonistsanalogs & derivativesantagonists & inhibitors

Narrower (3)

KHL 8430Sensitfendiline hydrochloride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2015
Highly Cited
2015
Inhibition of Acid Sphingomyelinase Depletes Cellular Phosphatidylserine and Mislocalizes K-Ras from the Plasma Membrane
ABSTRACT K-Ras must localize to the plasma membrane for biological activity; thus, preventing plasma membrane interaction blocks… 
2015
2015
Fendiline inhibits proliferation and invasion of pancreatic cancer cells by interfering with ADAM10 activation and β-catenin signaling
ADAM10 (A Disintegrin and Metalloprotease Domain 10) affects the pathophysiology of various cancers, and we had shown that… 
2002
2002
Arylalkylamines are a novel class of positive allosteric modulators at GABA(B) receptors in rat neocortex.
1998
1998
Open state block by fendiline of L-type Ca++ channels in ventricular myocytes from rat heart.
The effects of fendiline on L-type Ca++ currents [ICa(L)] were investigated in rat ventricular cardiomyocytes using the patch… 
1988
1988
The influence of calcium channel blockers on superoxide anions.
Highly Cited
1987
Highly Cited
1987
Differential effects of calcium entry blockers on pre- and postsynaptic influx of calcium in the rat hippocampus in vitro
Review
1987
Review
1987
Fendiline: a review of its basic pharmacological and clinical properties.
Fendiline is an anti-anginal agent for the treatment of coronary heart disease. Together with other diphenylalkylamines it is sub… 
1987
1987
Calmodulin antagonism: a pharmacological approach for the inhibition of mediator release from mast cells.
Highly Cited
1983
Highly Cited
1983
Interaction of verapamil and other calcium channel blockers with alpha 1- and alpha 2-adrenergic receptors.
To determine the specificity of the previously demonstrated competition of verapamil with radioligand binding to alpha-adrenergic… 
Highly Cited
1983
Highly Cited
1983
A fluorescent calmodulin that reports the binding of hydrophobic inhibitory ligands.
Ca2+ binding to calmodulin in the pCa range 5.5-7.0 exposes hydrophobic sites that bind hydrophobic inhibitory ligands, including… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)